Are you Dr. Charas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6800- Is this information wrong?
Clinical Trials
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. Start of enrollment: 2020 Oct 21
- Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer Start of enrollment: 2022 May 16
Publications & Presentations
PubMed
- 1 citationsImpact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.Neelam Tyagi, Elizabeth Hipp, Michelle Cloutier, Tomer Charas, Sandra Fontenla, James Mechalakos, Margie Hunt, Michael J. Zelefsky> ;Journal of Applied Clinical Medical Physics. 2019 Jul 1
- 32 citationsPlacement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.Amandeep Taggar, Tomer Charas, Gil'ad N. Cohen, Keeratikarn Boonyawan, Marisa A. Kollmeier, Sean McBride, Nitin Mathur, Antonio L. Damato, Michael J. Zelefsky> ;Brachytherapy. 2017 Dec 11
- 3 citationsSecond malignancy risk in prostate cancer and radiotherapy.Tomer Charas, Amandeep Taggar, Michael J. Zelefsky> ;Future Oncology. 2017 Jan 17
